Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance the medical research council ely prospective study 1990-2000

Diabetes

Volumn 57, Issue 10, 2008, Pages 2619-2625

  Forouhi, Nita G ^a   Luan, JiaN'An ^a   Cooper, Andrew ^a   Boucher, Barbara J ^b   Wareham, Nicholas J ^a  

^a INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; GLUCOSE; INSULIN; LIPID; PARATHYROID HORMONE; SOMATOMEDIN BINDING PROTEIN 1; 25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; DRUG DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CALCIUM BLOOD LEVEL; CIGARETTE SMOKING; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GROUPS BY AGE; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; MEDICAL RESEARCH; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEASONAL VARIATION; SEX DIFFERENCE; SOCIAL CLASS; SUMMER; BLOOD; BLOOD PRESSURE; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; PHYSIOLOGY; STATISTICAL MODEL;

ADULT; AGED; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VITAMIN D;

EID: 58149346072     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0593     Document Type: Article

References (41)

1. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF: The role of vitamin D in cancer prevention. Am, J Public Health 96:252-261, 2006
2. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008
3. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A: Serum 25- hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296:2832-2838, 2006
4. Mathieu C, Badenhoop K: Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab 16:261-266, 2005
5. Chiu KC, Chu A, Go VL, Saad MF: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am, J Clin Nutr 79:820- 825, 2004
6. Ford ES, Ajani UA, McGuire LC, Liu S: Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28:1228-1230, 2005
7. Hypponen E, Boucher BJ, Berry DJ, Power C: 25-hydroxyvitamin D, insulin-like growth factor 1 and metabolic syndrome at age 45y: a cross-sectional study in the 1958 British birth cohort. Diabetes 57:298-305, 2008
8. Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJW: Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians. Diabetologia 38:1239-1245, 1995
9. Boucher BJ: Inadequate vitamin D status: does it contribute to the disorders comprising syndrome 'X'? Br J Nutr 79:315-327, 1998
10. Scragg R, Sowers M, Bell C: Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27:2813-2818, 2004
11. Pittas AG, Lau J, Hu FB, Dawson-Hughes B: The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017-2029, 2007
12. Zittermann A: Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 89:552-572, 2003
13. Chiu KC, Chuang LM, Yoon C: The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. BMC Med Genet 2:2, 2001
14. Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, North BV, Mannan N, McDermott MF, DeLuca HF, Hitman GA: Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 51:2294-2300, 2002
15. Ortlepp JR, Metrikat J, Albrecht M, von KA, Hanrath P, Hoffmann R: The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet Med 20:451-454, 2003
16. Hitman GA, Mannan N, McDermott MF, Aganna E, Ogunkolade BW, Hales CN, Boucher BJ: Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians. Diabetes 47:688 -690, 1998
17. Gomez JM, Maravall FJ, Gomez N, Navarro MA, Casamitjana R, Soler J: Relationship between 25-(OH) D3, the IGF-I system, leptin, anthropomet- ric and body composition variables in a healthy, randomly selected population. Horm Metab Res 36:48-53, 2004
18. Gomez JM: The role of insulin-like growth factor I components in the regulation of vitamin D. Curr Pharm Biotechnol 7:125-132, 2006
19. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ: Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359:1740-1745, 2002
20. Need AG, O'Loughlin PD, Horowitz M, Nordin BE: Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf) 62:738 -741, 2005
21. Mattila C, Knekt P, Mannisto S, Rissanen H, Laaksonen MA, Montonen J, Reunanen A: Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30:2569-2570, 2007
22. Pittas AG, Dawson-Hughes B, Li T, van Dam RM, Willett WC, Manson JE, Hu FB: Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29:650-656, 2006
23. de Boer I, Tinker LF, Connelly S, Curb JD, Howard BV, Kestenbaum B, Larson JC, Manson JE, Margolis KL, Siscovick DS, Weiss NS: Calcium plus vitamin D supplementation and the risk of incident diabetes mellitus in the Women's Health Initiative. Diabetes Care 31:701-707, 2008
24. Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN: Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 22:262-270, 1999
25. Williams DR, Wareham NJ, Brown DC, Byrne CD, Clark PM, Cox BD, Cox LJ, Day NE, Hales CN, Palmer CR: Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med 12:30-35, 1995
26. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999
27. Heald AH, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A, Sampayo J, Taylor W, Fraser W, White A, Gibson JM: Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 44:333-339, 2001
28. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Sallis JF, Paffenbarger RS Jr: Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25:71-80, 1993
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
30. Franks PW, Ekelund U, Brage S, Wong MY, Wareham NJ: Does the association of habitual physical activity with the metabolic syndrome differ by level of cardiorespiratory fitness? Diabetes Care 27:1187-1193, 2004
31. Scragg R: Sunlight, vitamin D and cardiovascular disease. In Calcium- Regulating Hormones and CardiovascularFunction. Crass MF, Avioli LV, Eds. Boca Raton, CRC Press, 1994, p. 213-237
32. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC: Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49:1063-1069, 2007
33. Cruickshank JK, Heald AH, Anderson S, Cade JE, Sampayo J, Riste LK, Greenhalgh A, Taylor W, Fraser W, White A, Gibson JM: Epidemiology of the insulin-like growth factor system in three ethnic groups. Am J Epidemiol 154:504-513, 2001
34. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B: The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in non-diabetic adults. Diabetes Care 30:980-986, 2007
35. Tai K, Need AG, Horowitz M, Chapman IM: Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition 24:279-285, 2008
36. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe- Court D, Aganna E, Price CP, Boucher BJ: Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 95:787-796, 2002
37. Chiu KC, Chuang LM, Lee NP, Ryu JM, McGullam JL, Tsai GP, Saad MF: Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism 49:1501-1505, 2000
38. Oh JY, Barrett-Connor E: Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community- dwelling older adults: the Rancho Bernardo Study. Metabolism 51:356-359, 2002
39. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D: Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 10:185-197, 2008
40. Holick MF: Vitamin D deficiency. N Engl J Med 357:266-281, 2007
41. Webb AR, Kline L, Holick MF: Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67:373-378, 1988